Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VX-770: 107 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
107
Total FAERS Reports
2 (1.9%)
Deaths Reported
48
Hospitalizations
107
As Primary/Secondary Suspect

First Report: 2012 · Latest Report: 20140519

What Are the Most Common VX-770 Side Effects?

#1 Most Reported
Infective pulmonary exacerbation of cystic fibrosis
16 reports (15.0%)
#2 Most Reported
Headache
12 reports (11.2%)
#3 Most Reported
Pneumonia
11 reports (10.3%)

All VX-770 Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Infective pulmonary exacerbation of cystic fibrosis 16 15.0% 0 16
Headache 12 11.2% 0 4
Nasopharyngitis 11 10.3% 0 3
Pneumonia 11 10.3% 0 8
Cough 10 9.4% 0 3
Drug dose omission 10 9.4% 0 3
Malaise 7 6.5% 0 3
Dyspnoea 6 5.6% 0 2

Who Reports VX-770 Side Effects? Age & Gender Data

Average age: 23.8 years. Most reports from: US. View detailed demographics →

Is VX-770 Getting Safer? Reports by Year

YearReportsDeathsHosp.
2012 9 0 5
2013 23 1 16
2014 45 1 22

View full timeline →

What Is VX-770 Used For?

IndicationReports
Cystic fibrosis 107

VX-770 vs Alternatives: Which Is Safer?

VX-770 vs XOLAIR VX-770 vs ABATACEPT VX-770 vs ACETAMINOPHEN VX-770 vs ACETYLCYSTEINE VX-770 vs ACLIDINIUM VX-770 vs ACYCLOVIR VX-770 vs ADALIMUMAB VX-770 vs ADVAIR VX-770 vs ALBUTEROL VX-770 vs ALBUTEROL\IPRATROPIUM

Official FDA Label for VX-770

Official prescribing information from the FDA-approved drug label.